O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Denise Adams, MD
University of Vermont
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital
Montreal, Quebec, Canada
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California San Diego Cancer Center
La Jolla, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- City of Hope National Medical Center
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center
Gainesville, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Children'S Memorial Hospital, Chicago
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Boston Floating Hospital Infants and Children
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Children'S Hospital of Michigan
Detroit, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Cardinal Glennon Children'S Hospital
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Columbia Presbyterian Hospital
New York, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Nyu School of Medicine'S Kaplan Comprehensive Cancer Center
New York, New York, United States
- State University of New York - Upstate Medical University
Syracuse, New York, United States
- Graham Children'S Health Center
Asheville, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 1999
- Primary completion
- 31 Mar 2006
- Completion
- —
- Last update posted
- 5 Feb 2013
- Registered enrollment
- 36
- Registry id
- NCT00003765
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.